BETA


2021/2616(DEA) Examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products

Progress: Preparatory phase in Parliament

RoleCommitteeRapporteurShadows
Lead ENVI CANFIN Pascal (icon: Renew Renew)

Events

2021/04/26
   Indicative plenary sitting date
2021/04/07
   CSL - Delegated act not objected by Council
2021/03/24
   EC - Non-legislative basic document
Documents
2021/03/24
   EC - Non-legislative basic document published
Documents
2021/03/24
   EP/CSL - Initial period for examining delegated act 3 month(s)
2021/03/09
   EP - CANFIN Pascal (Renew) appointed as rapporteur in ENVI

Documents

History

(these mark the time of scraping, not the official date of the change)

docs/1
date
2021-04-23T00:00:00
docs
url: https://www.europarl.europa.eu/doceo/document/B-9-2021-0226_EN.html title: B9-0226/2021
type
Recommendation for early non-objection of delegated act
body
EP
procedure/dossier_of_the_committee
  • ENVI/9/05567
procedure/legal_basis
  • Rules of Procedure EP 0111-p6
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting Parliament's vote
forecasts
  • date: 2021-04-26T00:00:00 title: Indicative plenary sitting date
committees/0/rapporteur
  • name: CANFIN Pascal date: 2021-03-09T00:00:00 group: Renew Europe group abbr: Renew
events/2
date
2021-04-07T00:00:00
type
Delegated act not objected by Council
body
CSL